Last patient last visit complete in SPL026 Phase IIa clinical trial with topline results expected early in Q1 European patent granted for synthetic… Read More Post navigation SNIPR Biome further strengthens CRISPR/Cas IP portfolio with patent grant Assaults on intellectual property are crushing American innovation
[Sponsored] PatSeer Announces the Launch of a New AI-driven Semantic Search Built on a Custom-TrainedGPT Model Jun 6, 2023
